PortfoliosLab logoPortfoliosLab logo
TSM vs. AXSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TSM vs. AXSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taiwan Semiconductor Manufacturing Company Limited (TSM) and Axsome Therapeutics, Inc. (AXSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TSM achieves a 33.71% return, which is significantly higher than AXSM's 19.36% return. Over the past 10 years, TSM has underperformed AXSM with an annualized return of 33.46%, while AXSM has yielded a comparatively higher 39.83% annualized return.


TSM

1D
0.23%
1M
-9.00%
6M
22.92%
YTD
33.71%
1Y
69.13%
3Y*
62.43%
5Y*
30.32%
10Y*
33.46%
ALL TIME*
16.20%

AXSM

1D
-7.10%
1M
-9.42%
6M
18.31%
YTD
19.36%
1Y
115.02%
3Y*
41.26%
5Y*
35.01%
10Y*
39.83%
ALL TIME*
34.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$153.10M$171.36M$209.26M
$6.03B$6.30B$6.05B

TSM vs. AXSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TSM
Taiwan Semiconductor Manufacturing Company Limited
33.71%55.91%92.58%42.33%-36.75%12.09%92.67%64.85%-3.50%41.46%
AXSM
Axsome Therapeutics, Inc.
19.36%115.86%6.31%3.19%104.16%-53.63%-21.18%3,565.25%-49.64%-17.04%

Correlation

The correlation between TSM and AXSM is 0.16, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.16

Correlation (3Y)
Balances recent behavior with more history.

0.15

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.19

Correlation (10Y)
Provides a long-term view across more market conditions.

0.16

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2015

0.16

Fundamentals

Market Cap

TSM:

$2.10T

AXSM:

$11.22B

EPS

TSM:

NT$432.27

AXSM:

-$3.72

PS Ratio

TSM:

15.26

AXSM:

15.58

PB Ratio

TSM:

10.56

AXSM:

204.46

Total Revenue (TTM)

TSM:

NT$4.45T

AXSM:

$708.24M

Gross Profit (TTM)

TSM:

NT$2.86T

AXSM:

$655.82M

EBITDA (TTM)

TSM:

NT$3.20T

AXSM:

-$172.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TSM vs. AXSM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TSM
TSM Risk / Return Rank: 8787
Overall Rank
TSM Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
TSM Sortino Ratio Rank: 8585
Sortino Ratio Rank
TSM Omega Ratio Rank: 8282
Omega Ratio Rank
TSM Calmar Ratio Rank: 8888
Calmar Ratio Rank
TSM Martin Ratio Rank: 9292
Martin Ratio Rank

AXSM
AXSM Risk / Return Rank: 9696
Overall Rank
AXSM Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AXSM Sortino Ratio Rank: 9797
Sortino Ratio Rank
AXSM Omega Ratio Rank: 9595
Omega Ratio Rank
AXSM Calmar Ratio Rank: 9797
Calmar Ratio Rank
AXSM Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TSM vs. AXSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taiwan Semiconductor Manufacturing Company Limited (TSM) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TSMAXSMDifference
Sharpe ratioReturn per unit of total volatility

-0.99

Sortino ratioReturn per unit of downside risk

-1.61

Omega ratioGain probability vs. loss probability

1.28

1.47

-0.19

Calmar ratioReturn relative to maximum drawdown

3.23

6.25

-3.03

Martin ratioReturn relative to average drawdown

10.80

18.02

-7.22

TSM vs. AXSM - Sharpe Ratio Comparison

The current TSM Sharpe Ratio is 1.71, which is lower than the AXSM Sharpe Ratio of 2.69. The chart below compares the historical Sharpe Ratios of TSM and AXSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TSM vs. AXSM - Drawdown Comparison

The maximum TSM drawdown since its inception was -89.08%, roughly equal to the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for TSM and AXSM.


Loading charts...

Drawdown Indicators


TSMAXSMDifference

Max Drawdown

Largest peak-to-trough decline

-89.08%

-86.65%

-2.43%

Max Drawdown (1Y)

Largest decline over 1 year

-21.55%

-18.50%

-3.05%

Max Drawdown (3Y)

Largest decline over 3 years

-36.82%

-32.69%

-4.13%

Max Drawdown (5Y)

Largest decline over 5 years

-56.47%

-61.08%

+4.61%

Max Drawdown (10Y)

Largest decline over 10 years

-56.47%

-81.26%

+24.79%

Current Drawdown

Current decline from peak

-15.35%

-14.57%

-0.78%

Average Drawdown

Average peak-to-trough decline

-42.69%

-39.06%

-3.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.43%

6.41%

+0.02%

Volatility

TSM vs. AXSM - Volatility Comparison

The current volatility for Taiwan Semiconductor Manufacturing Company Limited (TSM) is 13.76%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that TSM experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TSMAXSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.76%

14.94%

-1.18%

Volatility (6M)

Calculated over the trailing 6-month period

33.07%

28.72%

+4.35%

Volatility (1Y)

Calculated over the trailing 1-year period

40.75%

42.96%

-2.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.35%

70.11%

-31.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.75%

90.38%

-55.63%

Dividends

TSM vs. AXSM - Dividend Comparison

TSM's dividend yield for the trailing twelve months is around 0.87%, while AXSM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AXSM
Axsome Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TSM
Taiwan Semiconductor Manufacturing Company Limited
0.87%1.00%1.18%1.78%2.49%1.57%1.56%3.46%3.64%2.32%2.61%2.54%

Financials

TSM vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between Taiwan Semiconductor Manufacturing Company Limited and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

TSM vs. AXSM - Profitability Comparison

The chart below illustrates the profitability comparison between Taiwan Semiconductor Manufacturing Company Limited and Axsome Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

TSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Taiwan Semiconductor Manufacturing Company Limited reported a gross profit of 860.31B and revenue of 1.27T. Therefore, the gross margin over that period was 67.7%.

AXSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.

TSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Taiwan Semiconductor Manufacturing Company Limited reported an operating income of 766.60B and revenue of 1.27T, resulting in an operating margin of 60.3%.

AXSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.

TSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Taiwan Semiconductor Manufacturing Company Limited reported a net income of 706.56B and revenue of 1.27T, resulting in a net margin of 55.6%.

AXSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.


Frequently Asked Questions


TSM and AXSM have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AXSM has higher volatility (14.94%) compared to TSM (13.76%). In terms of maximum drawdown, TSM dropped -89.08% vs AXSM's -86.65%.

AXSM currently has the higher Sharpe Ratio (2.69 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TSM and AXSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer